Currently, only two GLP-1s are approved by the FDA to treat obesity: Wegovy and Saxenda (liraglutide)
Food sensitivities, however, result in low-grade inflammation that damages the gut and increases autoimmune conditions
These changes support long-term weight loss by addressing not just hunger, but also the underlying metabolic factors that contribute to weight gain
Effect of GLP-1 receptor agonists on bone mineral density, bone metabolism markers, and fracture risk in type 2 diabetes: a systematic review and meta-analysis
Unless you're experiencing significant side effects, your provider will probably increase the dose every four weeks until you're at the dose that works best for you 1.7mg or 2.4mg for most people
How is Zepbound different from other GLP-1 medications